nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—CYP3A4—bone cancer	0.572	1	CbGaD
Desipramine—SLC22A2—Cisplatin—bone cancer	0.0723	0.362	CbGbCtD
Desipramine—CYP2B6—Cisplatin—bone cancer	0.0375	0.188	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—bone cancer	0.0251	0.126	CbGbCtD
Desipramine—ABCB1—Cisplatin—bone cancer	0.0192	0.0965	CbGbCtD
Desipramine—ABCB1—Doxorubicin—bone cancer	0.0129	0.0647	CbGbCtD
Desipramine—ABCB1—Methotrexate—bone cancer	0.0125	0.0626	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—bone cancer	0.0121	0.0609	CbGbCtD
Desipramine—CYP3A4—Doxorubicin—bone cancer	0.00772	0.0387	CbGbCtD
Desipramine—Paresthesia of limbs—Methotrexate—bone cancer	0.00333	0.0476	CcSEcCtD
Desipramine—Inappropriate antidiuretic hormone secretion—Cisplatin—bone cancer	0.002	0.0286	CcSEcCtD
Desipramine—Raised liver function tests—Methotrexate—bone cancer	0.00138	0.0198	CcSEcCtD
Desipramine—Sudden death—Methotrexate—bone cancer	0.00125	0.0178	CcSEcCtD
Desipramine—Body temperature increased—Carboplatin—bone cancer	0.00112	0.016	CcSEcCtD
Desipramine—Azatadine—CYP3A4—bone cancer	0.0011	0.13	CrCbGaD
Desipramine—Clomipramine—GSTP1—bone cancer	0.00105	0.124	CrCbGaD
Desipramine—Cerebrovascular accident—Cisplatin—bone cancer	0.000861	0.0123	CcSEcCtD
Desipramine—Petechiae—Methotrexate—bone cancer	0.000775	0.0111	CcSEcCtD
Desipramine—Petechiae—Epirubicin—bone cancer	0.000726	0.0104	CcSEcCtD
Desipramine—Alimemazine—CYP3A4—bone cancer	0.000698	0.0825	CrCbGaD
Desipramine—Petechiae—Doxorubicin—bone cancer	0.000671	0.0096	CcSEcCtD
Desipramine—Ventricular extrasystoles—Epirubicin—bone cancer	0.000661	0.00945	CcSEcCtD
Desipramine—Nocturia—Epirubicin—bone cancer	0.000644	0.0092	CcSEcCtD
Desipramine—Acute coronary syndrome—Cisplatin—bone cancer	0.000641	0.00916	CcSEcCtD
Desipramine—Epinastine—CYP3A4—bone cancer	0.000639	0.0754	CrCbGaD
Desipramine—Neuropathy peripheral—Cisplatin—bone cancer	0.000638	0.00911	CcSEcCtD
Desipramine—Myocardial infarction—Cisplatin—bone cancer	0.000638	0.00911	CcSEcCtD
Desipramine—Stomatitis—Cisplatin—bone cancer	0.000634	0.00906	CcSEcCtD
Desipramine—Atrioventricular block—Epirubicin—bone cancer	0.000616	0.0088	CcSEcCtD
Desipramine—Ventricular extrasystoles—Doxorubicin—bone cancer	0.000612	0.00874	CcSEcCtD
Desipramine—Coordination abnormal—Epirubicin—bone cancer	0.000608	0.00869	CcSEcCtD
Desipramine—Mequitazine—CYP3A4—bone cancer	0.000601	0.071	CrCbGaD
Desipramine—Phosphatase alkaline increased—Epirubicin—bone cancer	0.000597	0.00853	CcSEcCtD
Desipramine—Ventricular tachycardia—Epirubicin—bone cancer	0.000597	0.00853	CcSEcCtD
Desipramine—Nocturia—Doxorubicin—bone cancer	0.000596	0.00851	CcSEcCtD
Desipramine—Oxcarbazepine—CYP3A4—bone cancer	0.000588	0.0695	CrCbGaD
Desipramine—Gynaecomastia—Methotrexate—bone cancer	0.000571	0.00816	CcSEcCtD
Desipramine—Atrioventricular block—Doxorubicin—bone cancer	0.00057	0.00814	CcSEcCtD
Desipramine—Coordination abnormal—Doxorubicin—bone cancer	0.000563	0.00804	CcSEcCtD
Desipramine—Ventricular tachycardia—Doxorubicin—bone cancer	0.000552	0.0079	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Doxorubicin—bone cancer	0.000552	0.0079	CcSEcCtD
Desipramine—Tinnitus—Cisplatin—bone cancer	0.000544	0.00778	CcSEcCtD
Desipramine—Flushing—Cisplatin—bone cancer	0.000542	0.00775	CcSEcCtD
Desipramine—Arrhythmia—Cisplatin—bone cancer	0.000522	0.00746	CcSEcCtD
Desipramine—Alopecia—Cisplatin—bone cancer	0.000516	0.00737	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.000498	0.00712	CcSEcCtD
Desipramine—Vascular purpura—Epirubicin—bone cancer	0.000484	0.00693	CcSEcCtD
Desipramine—Vision blurred—Cisplatin—bone cancer	0.000479	0.00685	CcSEcCtD
Desipramine—Tremor—Cisplatin—bone cancer	0.000476	0.00681	CcSEcCtD
Desipramine—Cerebrovascular accident—Methotrexate—bone cancer	0.000473	0.00676	CcSEcCtD
Desipramine—Ill-defined disorder—Cisplatin—bone cancer	0.000472	0.00674	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.000461	0.00659	CcSEcCtD
Desipramine—Malaise—Cisplatin—bone cancer	0.000458	0.00655	CcSEcCtD
Desipramine—Purpura—Epirubicin—bone cancer	0.00045	0.00643	CcSEcCtD
Desipramine—Vascular purpura—Doxorubicin—bone cancer	0.000448	0.00641	CcSEcCtD
Desipramine—Cerebrovascular accident—Epirubicin—bone cancer	0.000442	0.00632	CcSEcCtD
Desipramine—Convulsion—Cisplatin—bone cancer	0.00044	0.00629	CcSEcCtD
Desipramine—Ataxia—Methotrexate—bone cancer	0.000435	0.00622	CcSEcCtD
Desipramine—Anxiety—Cisplatin—bone cancer	0.000431	0.00616	CcSEcCtD
Desipramine—Liver function test abnormal—Methotrexate—bone cancer	0.000428	0.00611	CcSEcCtD
Desipramine—Discomfort—Cisplatin—bone cancer	0.000428	0.00611	CcSEcCtD
Desipramine—Purpura—Doxorubicin—bone cancer	0.000416	0.00595	CcSEcCtD
Desipramine—Oedema—Cisplatin—bone cancer	0.000415	0.00593	CcSEcCtD
Desipramine—Cerebrovascular accident—Doxorubicin—bone cancer	0.000409	0.00585	CcSEcCtD
Desipramine—Prochlorperazine—CYP3A4—bone cancer	0.000409	0.0483	CrCbGaD
Desipramine—Ataxia—Epirubicin—bone cancer	0.000408	0.00583	CcSEcCtD
Desipramine—Thrombocytopenia—Cisplatin—bone cancer	0.000406	0.00581	CcSEcCtD
Desipramine—Tachycardia—Cisplatin—bone cancer	0.000405	0.00579	CcSEcCtD
Desipramine—Carbamazepine—CYP3A4—bone cancer	0.000401	0.0474	CrCbGaD
Desipramine—Liver function test abnormal—Epirubicin—bone cancer	0.0004	0.00572	CcSEcCtD
Desipramine—Eosinophilia—Methotrexate—bone cancer	0.000396	0.00566	CcSEcCtD
Desipramine—Anorexia—Cisplatin—bone cancer	0.000395	0.00565	CcSEcCtD
Desipramine—Hypotension—Cisplatin—bone cancer	0.000388	0.00554	CcSEcCtD
Desipramine—Atomoxetine—CYP3A4—bone cancer	0.000378	0.0447	CrCbGaD
Desipramine—Ataxia—Doxorubicin—bone cancer	0.000377	0.00539	CcSEcCtD
Desipramine—Paraesthesia—Cisplatin—bone cancer	0.000372	0.00532	CcSEcCtD
Desipramine—Eosinophilia—Epirubicin—bone cancer	0.000371	0.0053	CcSEcCtD
Desipramine—Liver function test abnormal—Doxorubicin—bone cancer	0.00037	0.00529	CcSEcCtD
Desipramine—Mianserin—CYP3A4—bone cancer	0.000369	0.0437	CrCbGaD
Desipramine—Erectile dysfunction—Methotrexate—bone cancer	0.000369	0.00527	CcSEcCtD
Desipramine—Decreased appetite—Cisplatin—bone cancer	0.000361	0.00515	CcSEcCtD
Desipramine—Drowsiness—Methotrexate—bone cancer	0.000357	0.0051	CcSEcCtD
Desipramine—Depression—Methotrexate—bone cancer	0.000356	0.00509	CcSEcCtD
Desipramine—Stomatitis—Methotrexate—bone cancer	0.000348	0.00497	CcSEcCtD
Desipramine—Pollakiuria—Epirubicin—bone cancer	0.000346	0.00495	CcSEcCtD
Desipramine—Eosinophilia—Doxorubicin—bone cancer	0.000343	0.00491	CcSEcCtD
Desipramine—Feeling abnormal—Cisplatin—bone cancer	0.000342	0.00489	CcSEcCtD
Desipramine—Weight increased—Epirubicin—bone cancer	0.000341	0.00487	CcSEcCtD
Desipramine—Clomipramine—CYP3A4—bone cancer	0.000338	0.0399	CrCbGaD
Desipramine—Drowsiness—Epirubicin—bone cancer	0.000334	0.00477	CcSEcCtD
Desipramine—Agranulocytosis—Methotrexate—bone cancer	0.000333	0.00476	CcSEcCtD
Desipramine—Nortriptyline—CYP3A4—bone cancer	0.00033	0.039	CrCbGaD
Desipramine—Body temperature increased—Cisplatin—bone cancer	0.000328	0.00469	CcSEcCtD
Desipramine—Neuropathy peripheral—Epirubicin—bone cancer	0.000327	0.00468	CcSEcCtD
Desipramine—Jaundice—Epirubicin—bone cancer	0.000326	0.00465	CcSEcCtD
Desipramine—Stomatitis—Epirubicin—bone cancer	0.000326	0.00465	CcSEcCtD
Desipramine—Hepatitis—Methotrexate—bone cancer	0.00032	0.00458	CcSEcCtD
Desipramine—Pollakiuria—Doxorubicin—bone cancer	0.00032	0.00458	CcSEcCtD
Desipramine—Weight increased—Doxorubicin—bone cancer	0.000315	0.00451	CcSEcCtD
Desipramine—Agranulocytosis—Epirubicin—bone cancer	0.000312	0.00446	CcSEcCtD
Desipramine—Trimipramine—CYP3A4—bone cancer	0.000311	0.0367	CrCbGaD
Desipramine—Drowsiness—Doxorubicin—bone cancer	0.000309	0.00442	CcSEcCtD
Desipramine—Neuropathy peripheral—Doxorubicin—bone cancer	0.000303	0.00433	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—bone cancer	0.000301	0.00431	CcSEcCtD
Desipramine—Stomatitis—Doxorubicin—bone cancer	0.000301	0.00431	CcSEcCtD
Desipramine—Hepatitis—Epirubicin—bone cancer	0.0003	0.00429	CcSEcCtD
Desipramine—Tinnitus—Methotrexate—bone cancer	0.000299	0.00427	CcSEcCtD
Desipramine—Hypoaesthesia—Epirubicin—bone cancer	0.000298	0.00426	CcSEcCtD
Desipramine—Asthenia—Cisplatin—bone cancer	0.000298	0.00425	CcSEcCtD
Desipramine—Doxepin—CYP3A4—bone cancer	0.000296	0.035	CrCbGaD
Desipramine—Agranulocytosis—Doxorubicin—bone cancer	0.000288	0.00412	CcSEcCtD
Desipramine—Diarrhoea—Cisplatin—bone cancer	0.000284	0.00406	CcSEcCtD
Desipramine—Alopecia—Methotrexate—bone cancer	0.000283	0.00405	CcSEcCtD
Desipramine—Tinnitus—Epirubicin—bone cancer	0.00028	0.004	CcSEcCtD
Desipramine—Flushing—Epirubicin—bone cancer	0.000278	0.00398	CcSEcCtD
Desipramine—Hepatitis—Doxorubicin—bone cancer	0.000277	0.00397	CcSEcCtD
Desipramine—Hypoaesthesia—Doxorubicin—bone cancer	0.000276	0.00395	CcSEcCtD
Desipramine—Dysgeusia—Methotrexate—bone cancer	0.000273	0.0039	CcSEcCtD
Desipramine—Arrhythmia—Epirubicin—bone cancer	0.000268	0.00383	CcSEcCtD
Desipramine—Alopecia—Epirubicin—bone cancer	0.000265	0.00379	CcSEcCtD
Desipramine—Vomiting—Cisplatin—bone cancer	0.000264	0.00377	CcSEcCtD
Desipramine—Promazine—CYP3A4—bone cancer	0.000263	0.0311	CrCbGaD
Desipramine—Vision blurred—Methotrexate—bone cancer	0.000263	0.00376	CcSEcCtD
Desipramine—Rash—Cisplatin—bone cancer	0.000262	0.00374	CcSEcCtD
Desipramine—Dermatitis—Cisplatin—bone cancer	0.000261	0.00373	CcSEcCtD
Desipramine—Ill-defined disorder—Methotrexate—bone cancer	0.000259	0.0037	CcSEcCtD
Desipramine—Tinnitus—Doxorubicin—bone cancer	0.000259	0.0037	CcSEcCtD
Desipramine—Flushing—Doxorubicin—bone cancer	0.000257	0.00368	CcSEcCtD
Desipramine—Dysgeusia—Epirubicin—bone cancer	0.000256	0.00365	CcSEcCtD
Desipramine—Malaise—Methotrexate—bone cancer	0.000252	0.0036	CcSEcCtD
Desipramine—Arrhythmia—Doxorubicin—bone cancer	0.000248	0.00354	CcSEcCtD
Desipramine—Nausea—Cisplatin—bone cancer	0.000246	0.00352	CcSEcCtD
Desipramine—Vision blurred—Epirubicin—bone cancer	0.000246	0.00352	CcSEcCtD
Desipramine—Alopecia—Doxorubicin—bone cancer	0.000245	0.0035	CcSEcCtD
Desipramine—Ill-defined disorder—Epirubicin—bone cancer	0.000242	0.00346	CcSEcCtD
Desipramine—Convulsion—Methotrexate—bone cancer	0.000242	0.00345	CcSEcCtD
Desipramine—Agitation—Epirubicin—bone cancer	0.00024	0.00343	CcSEcCtD
Desipramine—Dysgeusia—Doxorubicin—bone cancer	0.000236	0.00338	CcSEcCtD
Desipramine—Malaise—Epirubicin—bone cancer	0.000235	0.00336	CcSEcCtD
Desipramine—Discomfort—Methotrexate—bone cancer	0.000235	0.00335	CcSEcCtD
Desipramine—Chlorpromazine—CYP3A4—bone cancer	0.000232	0.0274	CrCbGaD
Desipramine—Palpitations—Epirubicin—bone cancer	0.000231	0.0033	CcSEcCtD
Desipramine—Imipramine—CYP3A4—bone cancer	0.000231	0.0272	CrCbGaD
Desipramine—Confusional state—Methotrexate—bone cancer	0.00023	0.00328	CcSEcCtD
Desipramine—Amitriptyline—CYP3A4—bone cancer	0.000229	0.0271	CrCbGaD
Desipramine—Vision blurred—Doxorubicin—bone cancer	0.000228	0.00325	CcSEcCtD
Desipramine—Convulsion—Epirubicin—bone cancer	0.000226	0.00323	CcSEcCtD
Desipramine—Hypertension—Epirubicin—bone cancer	0.000225	0.00322	CcSEcCtD
Desipramine—Ill-defined disorder—Doxorubicin—bone cancer	0.000224	0.0032	CcSEcCtD
Desipramine—Thrombocytopenia—Methotrexate—bone cancer	0.000223	0.00319	CcSEcCtD
Desipramine—Agitation—Doxorubicin—bone cancer	0.000222	0.00317	CcSEcCtD
Desipramine—Anxiety—Epirubicin—bone cancer	0.000221	0.00317	CcSEcCtD
Desipramine—Discomfort—Epirubicin—bone cancer	0.00022	0.00314	CcSEcCtD
Desipramine—Malaise—Doxorubicin—bone cancer	0.000218	0.00311	CcSEcCtD
Desipramine—Dry mouth—Epirubicin—bone cancer	0.000217	0.00311	CcSEcCtD
Desipramine—Anorexia—Methotrexate—bone cancer	0.000217	0.0031	CcSEcCtD
Desipramine—Confusional state—Epirubicin—bone cancer	0.000215	0.00307	CcSEcCtD
Desipramine—Palpitations—Doxorubicin—bone cancer	0.000213	0.00305	CcSEcCtD
Desipramine—Oedema—Epirubicin—bone cancer	0.000213	0.00304	CcSEcCtD
Desipramine—Hypotension—Methotrexate—bone cancer	0.000213	0.00304	CcSEcCtD
Desipramine—Convulsion—Doxorubicin—bone cancer	0.000209	0.00299	CcSEcCtD
Desipramine—Thrombocytopenia—Epirubicin—bone cancer	0.000209	0.00298	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—bone cancer	0.000208	0.00298	CcSEcCtD
Desipramine—Tachycardia—Epirubicin—bone cancer	0.000208	0.00297	CcSEcCtD
Desipramine—Insomnia—Methotrexate—bone cancer	0.000206	0.00294	CcSEcCtD
Desipramine—Anxiety—Doxorubicin—bone cancer	0.000205	0.00293	CcSEcCtD
Desipramine—Paraesthesia—Methotrexate—bone cancer	0.000204	0.00292	CcSEcCtD
Desipramine—Discomfort—Doxorubicin—bone cancer	0.000203	0.0029	CcSEcCtD
Desipramine—Anorexia—Epirubicin—bone cancer	0.000203	0.0029	CcSEcCtD
Desipramine—Somnolence—Methotrexate—bone cancer	0.000202	0.00289	CcSEcCtD
Desipramine—Dry mouth—Doxorubicin—bone cancer	0.000201	0.00287	CcSEcCtD
Desipramine—Dyspepsia—Methotrexate—bone cancer	0.0002	0.00286	CcSEcCtD
Desipramine—Hypotension—Epirubicin—bone cancer	0.000199	0.00285	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—bone cancer	0.000199	0.00284	CcSEcCtD
Desipramine—Decreased appetite—Methotrexate—bone cancer	0.000198	0.00283	CcSEcCtD
Desipramine—Oedema—Doxorubicin—bone cancer	0.000197	0.00282	CcSEcCtD
Desipramine—Fatigue—Methotrexate—bone cancer	0.000196	0.00281	CcSEcCtD
Desipramine—Thrombocytopenia—Doxorubicin—bone cancer	0.000193	0.00276	CcSEcCtD
Desipramine—Insomnia—Epirubicin—bone cancer	0.000193	0.00275	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—bone cancer	0.000192	0.00275	CcSEcCtD
Desipramine—Paraesthesia—Epirubicin—bone cancer	0.000191	0.00273	CcSEcCtD
Desipramine—Somnolence—Epirubicin—bone cancer	0.000189	0.00271	CcSEcCtD
Desipramine—Anorexia—Doxorubicin—bone cancer	0.000188	0.00269	CcSEcCtD
Desipramine—Feeling abnormal—Methotrexate—bone cancer	0.000188	0.00268	CcSEcCtD
Desipramine—Dyspepsia—Epirubicin—bone cancer	0.000188	0.00268	CcSEcCtD
Desipramine—Decreased appetite—Epirubicin—bone cancer	0.000185	0.00265	CcSEcCtD
Desipramine—Hypotension—Doxorubicin—bone cancer	0.000184	0.00263	CcSEcCtD
Desipramine—Fatigue—Epirubicin—bone cancer	0.000184	0.00263	CcSEcCtD
Desipramine—Constipation—Epirubicin—bone cancer	0.000182	0.0026	CcSEcCtD
Desipramine—Urticaria—Methotrexate—bone cancer	0.000181	0.00258	CcSEcCtD
Desipramine—Abdominal pain—Methotrexate—bone cancer	0.00018	0.00257	CcSEcCtD
Desipramine—Body temperature increased—Methotrexate—bone cancer	0.00018	0.00257	CcSEcCtD
Desipramine—Insomnia—Doxorubicin—bone cancer	0.000178	0.00255	CcSEcCtD
Desipramine—Paraesthesia—Doxorubicin—bone cancer	0.000177	0.00253	CcSEcCtD
Desipramine—Feeling abnormal—Epirubicin—bone cancer	0.000176	0.00251	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—bone cancer	0.000175	0.0025	CcSEcCtD
Desipramine—Dyspepsia—Doxorubicin—bone cancer	0.000173	0.00248	CcSEcCtD
Desipramine—Decreased appetite—Doxorubicin—bone cancer	0.000171	0.00245	CcSEcCtD
Desipramine—Fatigue—Doxorubicin—bone cancer	0.00017	0.00243	CcSEcCtD
Desipramine—Urticaria—Epirubicin—bone cancer	0.000169	0.00242	CcSEcCtD
Desipramine—Constipation—Doxorubicin—bone cancer	0.000169	0.00241	CcSEcCtD
Desipramine—Body temperature increased—Epirubicin—bone cancer	0.000168	0.00241	CcSEcCtD
Desipramine—Abdominal pain—Epirubicin—bone cancer	0.000168	0.00241	CcSEcCtD
Desipramine—Asthenia—Methotrexate—bone cancer	0.000163	0.00233	CcSEcCtD
Desipramine—Feeling abnormal—Doxorubicin—bone cancer	0.000162	0.00232	CcSEcCtD
Desipramine—Pruritus—Methotrexate—bone cancer	0.000161	0.0023	CcSEcCtD
Desipramine—Urticaria—Doxorubicin—bone cancer	0.000157	0.00224	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—bone cancer	0.000156	0.00223	CcSEcCtD
Desipramine—Abdominal pain—Doxorubicin—bone cancer	0.000156	0.00223	CcSEcCtD
Desipramine—Diarrhoea—Methotrexate—bone cancer	0.000156	0.00223	CcSEcCtD
Desipramine—Asthenia—Epirubicin—bone cancer	0.000153	0.00218	CcSEcCtD
Desipramine—Pruritus—Epirubicin—bone cancer	0.000151	0.00215	CcSEcCtD
Desipramine—Dizziness—Methotrexate—bone cancer	0.000151	0.00215	CcSEcCtD
Desipramine—Diarrhoea—Epirubicin—bone cancer	0.000146	0.00208	CcSEcCtD
Desipramine—Vomiting—Methotrexate—bone cancer	0.000145	0.00207	CcSEcCtD
Desipramine—Rash—Methotrexate—bone cancer	0.000144	0.00205	CcSEcCtD
Desipramine—Dermatitis—Methotrexate—bone cancer	0.000143	0.00205	CcSEcCtD
Desipramine—Headache—Methotrexate—bone cancer	0.000143	0.00204	CcSEcCtD
Desipramine—Asthenia—Doxorubicin—bone cancer	0.000141	0.00202	CcSEcCtD
Desipramine—Dizziness—Epirubicin—bone cancer	0.000141	0.00201	CcSEcCtD
Desipramine—Pruritus—Doxorubicin—bone cancer	0.000139	0.00199	CcSEcCtD
Desipramine—Vomiting—Epirubicin—bone cancer	0.000135	0.00194	CcSEcCtD
Desipramine—Nausea—Methotrexate—bone cancer	0.000135	0.00193	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—bone cancer	0.000135	0.00193	CcSEcCtD
Desipramine—Rash—Epirubicin—bone cancer	0.000134	0.00192	CcSEcCtD
Desipramine—Dermatitis—Epirubicin—bone cancer	0.000134	0.00192	CcSEcCtD
Desipramine—Headache—Epirubicin—bone cancer	0.000133	0.00191	CcSEcCtD
Desipramine—Dizziness—Doxorubicin—bone cancer	0.00013	0.00186	CcSEcCtD
Desipramine—Nausea—Epirubicin—bone cancer	0.000127	0.00181	CcSEcCtD
Desipramine—Vomiting—Doxorubicin—bone cancer	0.000125	0.00179	CcSEcCtD
Desipramine—Rash—Doxorubicin—bone cancer	0.000124	0.00178	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—bone cancer	0.000124	0.00177	CcSEcCtD
Desipramine—Headache—Doxorubicin—bone cancer	0.000123	0.00176	CcSEcCtD
Desipramine—Nausea—Doxorubicin—bone cancer	0.000117	0.00167	CcSEcCtD
Desipramine—CHRM5—Signaling Pathways—SMO—bone cancer	4.34e-05	0.000289	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—GRM1—bone cancer	4.34e-05	0.000289	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—GRM1—bone cancer	4.32e-05	0.000288	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL3—bone cancer	4.31e-05	0.000287	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL3—bone cancer	4.3e-05	0.000287	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL3—bone cancer	4.29e-05	0.000286	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—GRM1—bone cancer	4.28e-05	0.000285	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL3—bone cancer	4.27e-05	0.000285	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL3—bone cancer	4.23e-05	0.000282	CbGpPWpGaD
Desipramine—DRD2—Circadian rythm related genes—TP53—bone cancer	4.21e-05	0.000281	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—ENO2—bone cancer	4.16e-05	0.000277	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—GNA11—bone cancer	4.14e-05	0.000276	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—DHFR—bone cancer	4.14e-05	0.000276	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NDUFA12—bone cancer	4.14e-05	0.000276	CbGpPWpGaD
Desipramine—CHRM1—Circadian rythm related genes—TP53—bone cancer	4.12e-05	0.000275	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.12e-05	0.000274	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—ENO2—bone cancer	4.1e-05	0.000273	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—GNA11—bone cancer	3.97e-05	0.000265	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—GNA11—bone cancer	3.87e-05	0.000258	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—DHFR—bone cancer	3.86e-05	0.000257	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—ATF1—bone cancer	3.85e-05	0.000257	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—ENO2—bone cancer	3.84e-05	0.000256	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—DHFR—bone cancer	3.8e-05	0.000253	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL3—bone cancer	3.76e-05	0.00025	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—SMO—bone cancer	3.72e-05	0.000248	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—ATF1—bone cancer	3.69e-05	0.000246	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—SMO—bone cancer	3.64e-05	0.000242	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—GNA11—bone cancer	3.61e-05	0.00024	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL3—bone cancer	3.6e-05	0.00024	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—DHFR—bone cancer	3.56e-05	0.000238	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—SMO—bone cancer	3.56e-05	0.000237	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—GNA11—bone cancer	3.55e-05	0.000237	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—SMO—bone cancer	3.54e-05	0.000236	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—CYP3A4—bone cancer	3.51e-05	0.000234	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NT5C3A—bone cancer	3.43e-05	0.000229	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—GNA11—bone cancer	3.4e-05	0.000227	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—GNA11—bone cancer	3.33e-05	0.000222	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—GNA11—bone cancer	3.33e-05	0.000222	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—ENO2—bone cancer	3.31e-05	0.00022	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—CYP3A4—bone cancer	3.27e-05	0.000218	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—GNA11—bone cancer	3.25e-05	0.000217	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—ENO2—bone cancer	3.24e-05	0.000216	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.24e-05	0.000216	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—GNA11—bone cancer	3.24e-05	0.000216	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—CYP3A4—bone cancer	3.22e-05	0.000215	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TGFBR2—bone cancer	3.21e-05	0.000214	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—ATF1—bone cancer	3.16e-05	0.000211	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SMO—bone cancer	3.12e-05	0.000208	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—ATF1—bone cancer	3.09e-05	0.000206	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL3—bone cancer	3.08e-05	0.000205	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TGFBR2—bone cancer	3.08e-05	0.000205	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SMO—bone cancer	3.07e-05	0.000205	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—DHFR—bone cancer	3.07e-05	0.000204	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SMO—bone cancer	3.07e-05	0.000204	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SMO—bone cancer	3.06e-05	0.000204	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SMO—bone cancer	3.05e-05	0.000203	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IGF1R—bone cancer	3.02e-05	0.000201	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—ATF1—bone cancer	3.02e-05	0.000201	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—CYP3A4—bone cancer	3.02e-05	0.000201	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SMO—bone cancer	3.02e-05	0.000201	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL3—bone cancer	3.02e-05	0.000201	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—ATF1—bone cancer	3.01e-05	0.0002	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—DHFR—bone cancer	3e-05	0.0002	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—GSTP1—bone cancer	3e-05	0.0002	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL3—bone cancer	2.95e-05	0.000196	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL3—bone cancer	2.93e-05	0.000195	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IGF1R—bone cancer	2.9e-05	0.000193	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—GNA11—bone cancer	2.87e-05	0.000191	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—GNA11—bone cancer	2.86e-05	0.00019	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—GNA11—bone cancer	2.81e-05	0.000187	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—GNA11—bone cancer	2.81e-05	0.000187	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—GNA11—bone cancer	2.8e-05	0.000187	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—GSTP1—bone cancer	2.8e-05	0.000186	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—GNA11—bone cancer	2.79e-05	0.000186	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—GNA11—bone cancer	2.79e-05	0.000186	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—GNA11—bone cancer	2.76e-05	0.000184	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—GSTP1—bone cancer	2.75e-05	0.000184	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.72e-05	0.000181	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—ATF1—bone cancer	2.65e-05	0.000177	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TGFBR2—bone cancer	2.64e-05	0.000176	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—ATF1—bone cancer	2.61e-05	0.000174	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—ATF1—bone cancer	2.61e-05	0.000174	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—CYP3A4—bone cancer	2.6e-05	0.000173	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—ATF1—bone cancer	2.6e-05	0.000173	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—ATF1—bone cancer	2.59e-05	0.000173	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL3—bone cancer	2.59e-05	0.000173	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—GSTP1—bone cancer	2.58e-05	0.000172	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TGFBR2—bone cancer	2.58e-05	0.000172	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—ATF1—bone cancer	2.56e-05	0.000171	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL3—bone cancer	2.55e-05	0.00017	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—CYP3A4—bone cancer	2.54e-05	0.00017	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL3—bone cancer	2.54e-05	0.000169	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL3—bone cancer	2.53e-05	0.000169	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL3—bone cancer	2.53e-05	0.000168	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	2.52e-05	0.000168	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	2.51e-05	0.000167	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL3—bone cancer	2.5e-05	0.000167	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ENO2—bone cancer	2.5e-05	0.000166	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IGF1R—bone cancer	2.48e-05	0.000165	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—PTGS2—bone cancer	2.48e-05	0.000165	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ENO2—bone cancer	2.44e-05	0.000162	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IGF1R—bone cancer	2.43e-05	0.000162	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.37e-05	0.000158	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IGF1R—bone cancer	2.36e-05	0.000157	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—PTGS2—bone cancer	2.34e-05	0.000156	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—DHFR—bone cancer	2.32e-05	0.000154	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ENO2—bone cancer	2.3e-05	0.000153	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—DHFR—bone cancer	2.26e-05	0.000151	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—GSTP1—bone cancer	2.22e-05	0.000148	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TGFBR2—bone cancer	2.21e-05	0.000148	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—KIT—bone cancer	2.19e-05	0.000146	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	2.18e-05	0.000145	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—GSTP1—bone cancer	2.18e-05	0.000145	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TGFBR2—bone cancer	2.17e-05	0.000145	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TGFBR2—bone cancer	2.17e-05	0.000144	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—GNA11—bone cancer	2.17e-05	0.000144	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TGFBR2—bone cancer	2.16e-05	0.000144	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	2.14e-05	0.000143	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—DHFR—bone cancer	2.13e-05	0.000142	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—GNA11—bone cancer	2.11e-05	0.000141	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—KIT—bone cancer	2.1e-05	0.00014	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IGF1R—bone cancer	2.08e-05	0.000139	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—BRAF—bone cancer	2.06e-05	0.000137	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IGF1R—bone cancer	2.05e-05	0.000137	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IGF1R—bone cancer	2.05e-05	0.000136	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IGF1R—bone cancer	2.04e-05	0.000136	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IGF1R—bone cancer	2.03e-05	0.000135	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IGF1R—bone cancer	2.01e-05	0.000134	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—EGFR—bone cancer	2e-05	0.000133	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GNA11—bone cancer	1.99e-05	0.000133	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—BRAF—bone cancer	1.97e-05	0.000132	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CYP3A4—bone cancer	1.96e-05	0.000131	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.95e-05	0.00013	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ENO2—bone cancer	1.95e-05	0.00013	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CYP3A4—bone cancer	1.92e-05	0.000128	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—EGFR—bone cancer	1.91e-05	0.000128	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.81e-05	0.00012	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—DHFR—bone cancer	1.81e-05	0.00012	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KIT—bone cancer	1.8e-05	0.00012	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KIT—bone cancer	1.76e-05	0.000117	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MDM2—bone cancer	1.73e-05	0.000115	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KIT—bone cancer	1.72e-05	0.000115	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KIT—bone cancer	1.71e-05	0.000114	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—BRAF—bone cancer	1.69e-05	0.000113	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GNA11—bone cancer	1.69e-05	0.000112	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—GSTP1—bone cancer	1.68e-05	0.000112	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—BRAF—bone cancer	1.65e-05	0.00011	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MDM2—bone cancer	1.65e-05	0.00011	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—GSTP1—bone cancer	1.64e-05	0.000109	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—EGFR—bone cancer	1.64e-05	0.000109	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—BRAF—bone cancer	1.62e-05	0.000108	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—BRAF—bone cancer	1.61e-05	0.000107	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—EGFR—bone cancer	1.6e-05	0.000107	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.57e-05	0.000104	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.56e-05	0.000104	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PTGS2—bone cancer	1.55e-05	0.000104	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—GSTP1—bone cancer	1.54e-05	0.000103	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.53e-05	0.000102	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.52e-05	0.000101	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KIT—bone cancer	1.51e-05	0.000101	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ENO2—bone cancer	1.5e-05	0.0001	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—JUN—bone cancer	1.5e-05	0.0001	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KIT—bone cancer	1.49e-05	9.91e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KIT—bone cancer	1.48e-05	9.89e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KIT—bone cancer	1.48e-05	9.85e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KIT—bone cancer	1.47e-05	9.82e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MMP9—bone cancer	1.46e-05	9.73e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KIT—bone cancer	1.46e-05	9.73e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PTGS2—bone cancer	1.45e-05	9.66e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—JUN—bone cancer	1.44e-05	9.58e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PTGS2—bone cancer	1.43e-05	9.51e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—BRAF—bone cancer	1.42e-05	9.46e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MDM2—bone cancer	1.42e-05	9.44e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MMP9—bone cancer	1.4e-05	9.32e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—BRAF—bone cancer	1.4e-05	9.31e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—BRAF—bone cancer	1.39e-05	9.29e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—DHFR—bone cancer	1.39e-05	9.29e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—BRAF—bone cancer	1.39e-05	9.26e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MDM2—bone cancer	1.39e-05	9.24e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—BRAF—bone cancer	1.39e-05	9.23e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—EGFR—bone cancer	1.38e-05	9.17e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—BRAF—bone cancer	1.37e-05	9.14e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MDM2—bone cancer	1.36e-05	9.03e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.35e-05	9.03e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—EGFR—bone cancer	1.35e-05	9.01e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MDM2—bone cancer	1.35e-05	8.98e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—EGFR—bone cancer	1.35e-05	8.98e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—EGFR—bone cancer	1.34e-05	8.95e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PTGS2—bone cancer	1.34e-05	8.92e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.33e-05	8.86e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—GSTP1—bone cancer	1.31e-05	8.72e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GNA11—bone cancer	1.3e-05	8.68e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—JUN—bone cancer	1.23e-05	8.21e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—JUN—bone cancer	1.2e-05	8.03e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MMP9—bone cancer	1.2e-05	7.98e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MDM2—bone cancer	1.19e-05	7.93e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—EGFR—bone cancer	1.18e-05	7.87e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—JUN—bone cancer	1.18e-05	7.85e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MMP9—bone cancer	1.17e-05	7.81e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—JUN—bone cancer	1.17e-05	7.81e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MDM2—bone cancer	1.17e-05	7.8e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MDM2—bone cancer	1.17e-05	7.79e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MDM2—bone cancer	1.16e-05	7.76e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MDM2—bone cancer	1.16e-05	7.74e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTGS2—bone cancer	1.15e-05	7.67e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MDM2—bone cancer	1.15e-05	7.66e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MMP9—bone cancer	1.15e-05	7.64e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MMP9—bone cancer	1.14e-05	7.6e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EGFR—bone cancer	1.13e-05	7.53e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTGS2—bone cancer	1.13e-05	7.52e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—JUN—bone cancer	1.03e-05	6.89e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—JUN—bone cancer	1.02e-05	6.78e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—JUN—bone cancer	1.02e-05	6.77e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—JUN—bone cancer	1.01e-05	6.75e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTP1—bone cancer	1.01e-05	6.73e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—JUN—bone cancer	1.01e-05	6.72e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MMP9—bone cancer	1.01e-05	6.71e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—JUN—bone cancer	9.99e-06	6.66e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—bone cancer	9.91e-06	6.6e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MMP9—bone cancer	9.9e-06	6.6e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MMP9—bone cancer	9.88e-06	6.58e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MMP9—bone cancer	9.85e-06	6.56e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MMP9—bone cancer	9.82e-06	6.54e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MMP9—bone cancer	9.72e-06	6.48e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—bone cancer	9.68e-06	6.45e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—bone cancer	9.49e-06	6.32e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—bone cancer	9.47e-06	6.31e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—bone cancer	9.26e-06	6.17e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—bone cancer	9.21e-06	6.14e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—bone cancer	8.7e-06	5.8e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—bone cancer	8.49e-06	5.66e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—bone cancer	8.13e-06	5.42e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—bone cancer	8.13e-06	5.42e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—bone cancer	8e-06	5.33e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—bone cancer	8e-06	5.33e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—bone cancer	7.98e-06	5.32e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—bone cancer	7.96e-06	5.3e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—bone cancer	7.95e-06	5.3e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—bone cancer	7.93e-06	5.29e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—bone cancer	7.85e-06	5.24e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—bone cancer	7.78e-06	5.18e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—bone cancer	7.74e-06	5.16e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—bone cancer	6.83e-06	4.55e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—bone cancer	6.78e-06	4.52e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—bone cancer	6.72e-06	4.48e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—bone cancer	6.7e-06	4.47e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—bone cancer	6.68e-06	4.45e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—bone cancer	6.66e-06	4.44e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—bone cancer	6.6e-06	4.4e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—bone cancer	5.23e-06	3.49e-05	CbGpPWpGaD
